Literature DB >> 314957

In vitro primary immunization of human peripheral blood lymphocytes to KLH: evidence for HLA-D region restriction.

G E Rodey, L K Luehrman, D W Thomas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 314957

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  8 in total

1.  Primary and secondary human in vitro T-cell responses to soluble antigens are mediated by subsets bearing different CD45 isoforms.

Authors:  M Plebanski; M Saunders; S S Burtles; S Crowe; D C Hooper
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

2.  Induction of in vitro autoimmune responses by mononuclear blood cells in Hashimoto's thyroiditis.

Authors:  S A Stern; P C Dau
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

3.  Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids.

Authors:  R D Salter; D N Howell; P Cresswell
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

Review 4.  Regulatory properties of mononuclear phagocytes reflect specialized functional status.

Authors:  M J Parmely
Journal:  Surv Immunol Res       Date:  1984

5.  Unusual restriction of a proliferative line reacting with influenza A and B viruses.

Authors:  G Sterkers; C Hannoun; J P Levy
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

6.  Tuberculin purified protein derivative-reactive T cells in cord blood lymphocytes.

Authors:  H Shiratsuchi; I Tsuyuguchi
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

7.  Malaria specific human T cell clones: crossreactivity with various plasmodia species.

Authors:  P Simitsek; C Chizzolini; L Perrin
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

8.  Genetics of human T cell-monocyte interaction in helper cell induction.

Authors:  A Rees; M Feldmann; J N Woody; P Erb
Journal:  Clin Exp Immunol       Date:  1981-06       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.